HIMCH
ACOR

Hartford Investment Management Co (HIMCO)’s Acorda Therapeutics ACOR Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-73
Closed -$252K – 840
2018
Q2 		$252K Buy
+73
New +$224K 0.01% 678
2017
Q3 		– Sell
-103
Closed -$242K – 642
2017
Q2 		$242K Buy
+103
New +$204K ﹤0.01% 566

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s ACOR Position: Q3 2018 in Review

Hartford Investment Management Co (HIMCO) sold out of Acorda Therapeutics (ACOR) in Q3 2018, closing a stake of 73 shares — an estimated $252K sold.

Hartford Investment Management Co (HIMCO) first reported a position in ACOR in Q2 2017 and held it in 2 quarters. The position peaked at $252K in Q2 2018. 174 funds tracked by Wall St. Rank hold ACOR as of Q3 2018.

  • Hartford Investment Management Co (HIMCO) reported no remaining Acorda Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 73 Acorda Therapeutics shares in Q3 2018, an estimated $252K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Acorda Therapeutics in Q2 2017 and held it in 2 quarters.
  • Hartford Investment Management Co (HIMCO)'s Acorda Therapeutics position peaked at $252K in Q2 2018.
  • 174 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2018.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q3 2018, filed 8 Nov 2018.